Registered capital: Baht 100,000,000 Total number of share: 1,000,000 shares Par value: Baht 100 per share Paid-up capital: Baht 100,000,000 Shareholding structure: The Company holds 100 percent of its total
Registered capital: EUR 25,000 (or approximately Baht 960,000) Total number of share: 25,000 Shares Par value: EUR 1 per share Paid-up capital: EUR 25,000 (or approximately Baht 960,000) Shareholding Structure
: Thailand Type of business: Invest in other company’s securities and operate hotel business Registered capital: Baht 300,000,000 Total number of share: 3,000,000 shares Par value: Baht 100 per share Paid-up
master franchise agreement under various brands including GRAM Pancakes and PABLO Cheesetart, 202,966 shares at par value of Baht 100 per share. After the acquisition, the Company will hold 99.99% shares
January 27, 2020 has approved the establishment of subsidiary. The details are as follows; Registered Name MAHADLEKLUANG Co., Ltd. Type of business Real Estate Development Ratio of share held by the Company
Development Public Company Limited (“The Company”) would like to inform that total revenues 1,843.42 million baht and net loss 79.96 million baht in the consolidated financial statement for three months of 2020
) Business purpose: Provide fiber optic network in the industrial park of Sahapat Group Registered capital: 300,000 shares at 100 Baht per share, in total of 30,000,000 Baht Paid-up capital: Not yet paid-up
: Reflect good performance into the consolidated financial statements, value of firm and dividend. 7. Source of fund Cash from increase newly share capital to private placement of Baht 644 million. The
reviewed consolidated financial statements for the 9-month period as of 30 September 2018. The transaction value is also calculated from the transactions of disposal of asset during the period of six months
. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public